Table 4. Stratified analyses between TNFSF4 rs3850641 polymorphism and the risk of myocardial infarction.

Variable	TNFSF4 rs3850641 (case/control)			GG vs. AA	GG+AG vs. AA	GG vs. AG+AA
	GG	AG	AA
Sex
Male	17/8	83/89	186/235	2.68 (1.13,6.36);0.025	1.30 (0.93,1.83);0.127	2.56 (1.09,6.02);0.031
Female	8/7	45/46	114/125	1.25 (0.44,3.57);0.672	1.10 (0.69,1.73);0.693	1.23 (0.44,3.47);0.697
Age
<60	12/6	51/64	139/164	2.36 (0.86,6.45);0.094	1.06 (0.71,1.60);0.773	2.40 (0.88,6.52);0.086
≥60	13/9	77/71	161/196	1.76 (0.73,4.22);0.206	1.37 (0.95,1.98);0.092	1.62 (0.68,3.86);0.276
Smoking status
Nonsmoker	14/14	47/92	122/251	2.06 (0.95,4.45);0.067	1.18 (0.81,1.74);0.386	2.03 (0.95,4.35);0.069
Smoke	11/1	81/43	178/109	6.74 (0.86,52.90);0.070	1.28 (0.83,1.97);0.621	6.46 (0.83,50.49);0.076
Drinking status
No	15/14	99/105	214/315	1.39 (1.00,1.92);0.233	1.41 (1.03,1.92);0.030	1.44 (0.68,3.02);0.338
Yes	10/1	29/30	86/45	5.23 (0.65,42.18);0.120	0.66 (0.36,1.19);0.168	6.52 (0.82,52.00);0.070
Hypertension
No	10/7	50/85	125/207	0.97 (0.64,1.47);0.974	1.08 (0.73,1.60);0.702	2.38 (0.89,6.38);0.084
Yes	15/8	78/50	175/173	2.37 (0.88,6.37);0.089	1.40 (0.95,2.08);0.092	1.50 (0.63,3.62);0.362
Diabetes
No	18/11	81/114	195/308	2.59 (1.20,5.59);0.016	1.25(0.91,1.72);0.169	2.50 (1.16,5.38);0.019
Yes	7/4	47/21	105/52	0.87 (0.24,3.09);0.826	1.07 (0.60,1.91);0.820	0.84 (0.24,2.96);0.797

Bold values are statistically significant (P<0.05).